The generic prescription drug memantine is also available as brand-name Namenda. It comes in three forms: immediate-release tablet, oral solution, and extended-release capsule. Memantine is prescribed ...

The dementia drug memantine showed promise for improving social functioning in a small trial of youth with autism. Nine of 16 children and adolescents treated with memantine met the response criteria ...

Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of ...

Memantine is approved to treat moderate to severe Alzheimer's disease and other dementias. Evidence suggests that it might also be useful with bipolar disorder, depression, schizophrenia and much more ...

August 24, 2010 — The adamantine derivative, memantine, preferentially blocks excessive extrasynaptic activity of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors (NMDAR), while largely ...

In a disappointing turn for Down's syndrome (DS) research, a trial to evaluate potential cognitive benefits of the drug memantine—already used as a treatment in Alzheimer's disease—showed no ...

MIAMI — A drug that for years has been approved to treat moderate to severe Alzheimer's disease may have a role in improving the cognitive deficits associated with bipolar disorder. In a randomized, ...

The drug memantine can benefit patients with moderate to severe Alzheimer's disease, according to a study reported in the April 3 New England Journal of Medicine. The use of memantine for Alzheimer's ...

The Food and Drug Administration approved the German medication memantine today to help ease the severe symptoms of an estimated 1 million Americans who suffer from the late stages of Alzheimer's ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...